Clinical Trial Update: Study of LW402 Tablets in Moderate to Severe Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

A Phase 2 study of LW402 tablets for rheumatoid arthritis has completed the trial status and is marked as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• LW402

Snippet

Sponsor: Shanghai Longwood Biopharmaceuticals Co., Ltd. | Conditions: Arthritis, Rheumatoid | Phase 2 | Status: COMPLETED